中国胸心血管外科临床杂志

中国胸心血管外科临床杂志

胸腔镜解剖性肺段切除术治疗早期非小细胞肺癌的应用进展

查看全文

肺癌的发病率及死亡率在全球范围内越来越高,随着 CT 的普及,越来越多的早期肺癌能被及时发现和治疗。手术作为肺癌的主要治疗方式,胸腔镜下解剖性肺段切除术在非小细胞肺癌中的治疗作用正引起胸外科医生们的关注。在此,我们将讨论胸腔镜解剖性肺段切除术在治疗早期非小细胞肺癌中的应用。

The incidence and mortality of lung cancer are increasing globally. With the spread of CT, more and more early-stage lung cancer can be detected and treated in a timely manner. As the main treatment of lung cancer, thoracoscopic anatomical segmentectomy in the treatment of non-small cell lung cancer is causing concern to the thoracic surgeons. Here, we will discuss the application of thoracoscopic anatomical segmentectomy in the treatment of early non-small cell lung cancer.

关键词: 解剖性肺段切除术; 非小细胞肺癌; 立体定向放疗消融术

Key words: Thoracoscopic anatomical segmentectomy; non-small cell lung cancer; stereotactic body radiotherapy

引用本文: 陈晓峰, 王安. 胸腔镜解剖性肺段切除术治疗早期非小细胞肺癌的应用进展. 中国胸心血管外科临床杂志, 2018, 25(11): 1000-1002. doi: 10.7507/1007-4848.201804024 复制

登录后 ,请手动点击刷新查看全文内容。 没有账号,
1. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin, 2016, 66(2): 115-132.
2. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin, 2011, 61(2): 69-90.
3. Ettinger DS, Wood DE, Akerley W, et al. Non-small cell lung cancer, version 1.2015. J Natl Compr Canc Netw, 2014, 12(12): 1738-1761.
4. Kirby TJ, Rice TW. Thoracoscopic lobectomy. Ann Thorac Surg, 1993, 56(3): 784-786.
5. Churchill ED, Belsey R. Segmental pneumonectomy in bronchiectasis: The lingula segment of the left upper lobe. Ann Surg, 1939, 109(4): 481-499.
6. Murakami S, Watanabe Y, Shimizu J, et al. Second surgical intervention for contralateral recurrence or second primary lung cancer. Kyobu Geka, 1989, 42(9): 722-726.
7. Shapiro M, Weiser TS, Wisnivesky JP, et al. Thoracoscopic segmentectomy compares favorably with thoracoscopic lobectomy for patients with small stage Ⅰ lung cancer. J Thorac Cardiovasc Surg, 2009, 137(6): 1388-1393.
8. Leshnower BG, Miller DL, Fernandez FG, et al. Video-assisted thoracoscopic surgery segmentectomy: a safe and effective procedure. Ann Thorac Surg, 2010, 89(5): 1571-1576.
9. Deng B, Cassivi SD, de Andrade M, et al. Clinical outcomes and changes in lung function after segmentectomy versus lobectomy for lung cancer cases. J Thorac Cardiovasc Surg, 2014, 148(4): 1186-1192.
10. Cao J, Yuan P, Wang Y, et al. Survival rates after lobectomy, segmentectomy, and wedge resection for non-small cell lung cancer. Ann Thorac Surg, 2018, 105(5): 1483-1491.
11. Zhang L, Li M, Yin R, et al. Comparison of the oncologic outcomes of anatomic segmentectomy and lobectomy for early-stage non-small cell lung cancer. Ann Thorac Surg, 2015, 99(2): 728-737.
12. Hou B, Deng XF, Zhou D, et al. Segmentectomy versus wedge resection for the treatment of high-risk operable patients with stage Ⅰ non-small cell lung cancer: a meta-analysis. Ther Adv Respir Dis, 2016, 10(5): 435-443.
13. Harada H, Okada M, Sakamoto T, et al. Functional advantage after radical segmentectomy versus lobectomy for lung cancer. Ann Thorac Surg, 2005, 80(6): 2041-2045.
14. Ghaly G, Kamel M, Nasar A, et al. Video-assisted thoracoscopic surgery is a safe and effective alternative to thoracotomy for anatomical segmentectomy in patients with clinical stage Ⅰ non-small cell lung cancer. Ann Thorac Surg, 2016, 101(2): 465-472.
15. Yao F, Wang J, Yao J, et al. Early experience with video-assisted thoracoscopic anatomic segmentectomy. J Laparoendosc Adv Surg Tech A, 2018, 28(7): 819-826.
16. Altorki NK, Kamel MK, Narula N, et al. Anatomical segmentectomy and wedge resections are associated with comparable outcomes for patients with small cT1N0 non-small cell lung cancer. J Thorac Oncol, 2016, 11(11): 1984-1992.
17. Sagawa M, Oizumi H, Suzuki H, et al. A prospective 5-year follow-up study after limited resection for lung cancer with ground-glass opacity. Eur J Cardiothorac Surg, 2018, 53(4): 849-856.
18. Kent MS, Mandrekar SJ, Landreneau R, et al. Impact of sublobar resection on pulmonary function: long-term results from American College of Surgeons Oncology Group Z4032(Alliance). Ann Thorac Surg, 2016, 102(1): 230-238.
19. Chang JY, Senan S, Paul MA, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage Ⅰ non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol, 2015, 16(6): 630-637.
20. Ezer N, Veluswamy RR, Mhango G, et al. Outcomes after stereotactic body radiotherapy versus limited resection in older patients with early-stage lung cancer. J Thorac Oncol, 2015, 10(8): 1201-1206.
21. Zheng X, Schipper M, Kidwell K, et al. Survival outcome after stereotactic body radiation therapy and surgery for stage Ⅰ non-small cell lung cancer: a meta-analysis. Int J Radiat Oncol Biol Phys, 2014, 90(3): 603-611.